1 active not recruiting, 1 completed, 1 recruiting. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Active not recruiting 1, Completed 1, Recruiting 1 |
Follow LY03020: new trials by email Literature Review of LY03020 trials Research Report on LY03020
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 1 MAD Study to Evaluate the Safety and Tolerability of LY03020 LY03020, Placebo - Schizophrenia, Alzheimer's Disease Psychosis | Phase 1 | Recruiting | Luye Pharma Group Ltd. | 40 | 2025-08-20 | 2025-11-19 |
| A Food Effect Study of LY03020 in Healthy Subjects LY03020 - Schizophrenia, Alzheimer's Disease Psychosis | Phase 1 | Active not recruiting | Luye Pharma Group Ltd. | 16 | 2025-07-30 | 2025-12-18 |
| A Study Assessing the Safety and Tolerability of LY03020 in Chinese Healthy Subjects LY03020, Placebo - Schizophrenia, Alzheimer's Disease Psychosis | Phase 1 | Completed | Luye Pharma Group Ltd. | 66 | 2024-08-19 | 2025-05-29 |
Schizophrenia (3)
China (3)
Gang Wang (1)